Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Sep;52(9):688–692. doi: 10.1136/jcp.52.9.688

Immunophenotyping of acute lymphoblastic leukaemia in routinely processed bone marrow biopsy specimens.

B Toth 1, M Wehrmann 1, E Kaiserling 1, H P Horny 1
PMCID: PMC501546  PMID: 10655992

Abstract

AIMS: To assess the value of immunophenotyping of acute lymphoblastic leukaemia (ALL) in routinely processed bone marrow trephine biopsy specimens and to establish a minimum panel of antibodies to assess lymphoid lineage and enable differentiation from acute myeloid leukaemia. METHODS: 45 routinely processed bone marrow biopsy specimens (formalin fixed, paraffin embedded and mildly decalcified in EDTA) reported to contain leukaemic infiltrates on the basis of cytomorphological and enzyme-cytochemical analysis of bone marrow smears (22 c-ALL, 11 T-ALL, 2 B-ALL, 10 u-ALL (unclassified)) were immunostained by the ABC method with a broad panel of 26 antibodies against various haemopoietic antigens. RESULTS: Staining with antibodies directed against myeloperoxidase and lysozyme showed that seven cases were either biphenotypic or mixed leukaemias (2), or of myelogenous origin (acute myeloid leukaemia (AML)-M1 (2); AML-M4 (2); AML-M5a (1)). Five of these seven cases had been diagnosed initially as u-ALL. Three further cases with no compact leukaemic infiltrates were excluded. ALL was confirmed in the remaining 35 cases. Because of revised diagnoses, the total numbers of ALL subtypes changed (23 c-ALL, 8 T-ALL, 2 B-ALL, 2 u-ALL). Immunostaining of more than 10% of blast cells in at least one case was found with 19 of the 26 antibodies. The most sensitive lineage specific antibodies for diagnosis were found to be anti-CD10 for c-ALL (22/23) and beta F1 for T-ALL (6/8). Expression of aberrant antigens was fairly common--for example, 7/23 cases of c-ALL stained with antibodies against T cell associated antigens. CONCLUSIONS: Immunohistochemical investigation of routinely processed bone marrow biopsy specimens enables reliable detection of ALL subtypes c-ALL and T-ALL. A minimum panel of antibodies, against TdT, CD34, myeloperoxidase, lysozyme, CD10, CD79a, and CD20, and the antibody beta F1, is proposed for the immunophenotyping of acute leukaemia.

Full text

PDF
688

Images in this article

688Image
on p.688
689Image
on p.689
690Image
on p.690
690Image
on p.690

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buccheri V., Mihaljević B., Matutes E., Dyer M. J., Mason D. Y., Catovsky D. mb-1: a new marker for B-lineage lymphoblastic leukemia. Blood. 1993 Aug 1;82(3):853–857. [PubMed] [Google Scholar]
  2. Cartun R. W., Coles F. B., Pastuszak W. T. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. Am J Pathol. 1987 Dec;129(3):415–421. [PMC free article] [PubMed] [Google Scholar]
  3. Chuang S. S., Li C. Y. Useful panel of antibodies for the classification of acute leukemia by immunohistochemical methods in bone marrow trephine biopsy specimens. Am J Clin Pathol. 1997 Apr;107(4):410–418. doi: 10.1093/ajcp/107.4.410. [DOI] [PubMed] [Google Scholar]
  4. Clark J. R., Williams M. E., Swerdlow S. H. Detection of B- and T-cells in paraffin-embedded tissue sections. Diagnostic utility of commercially obtained 4KB5 and UCHL-1. Am J Clin Pathol. 1990 Jan;93(1):58–69. doi: 10.1093/ajcp/93.1.58. [DOI] [PubMed] [Google Scholar]
  5. Horny H. P., Engst U., Walz R. S., Kaiserling E. In situ immunophenotyping of lymphocytes in human bone marrow: an immunohistochemical study. Br J Haematol. 1989 Mar;71(3):313–321. doi: 10.1111/j.1365-2141.1989.tb04286.x. [DOI] [PubMed] [Google Scholar]
  6. Horny H. P., Kaiserling E. Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study. Br J Haematol. 1988 Aug;69(4):449–455. doi: 10.1111/j.1365-2141.1988.tb02397.x. [DOI] [PubMed] [Google Scholar]
  7. Horny H. P., Wehrmann M., Schlicker H. U., Eichstaedt A., Clemens M. R., Kaiserling E. QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens. J Clin Pathol. 1995 Apr;48(4):291–294. doi: 10.1136/jcp.48.4.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Horny H. P., Wehrmann M., Steinke B., Kaiserling E. Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies. Hum Pathol. 1994 Aug;25(8):810–814. doi: 10.1016/0046-8177(94)90251-8. [DOI] [PubMed] [Google Scholar]
  9. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  10. Kurec A. S., Cruz V. E., Barrett D., Mason D. Y., Davey F. R. Immunophenotyping of acute leukemias using paraffin-embedded tissue sections. Am J Clin Pathol. 1990 Apr;93(4):502–509. doi: 10.1093/ajcp/93.4.502. [DOI] [PubMed] [Google Scholar]
  11. Majdic O., Stöckl J., Pickl W. F., Bohuslav J., Strobl H., Scheinecker C., Stockinger H., Knapp W. Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood. 1994 Mar 1;83(5):1226–1234. [PubMed] [Google Scholar]
  12. Mason D. Y., Cordell J. L., Brown M. H., Borst J., Jones M., Pulford K., Jaffe E., Ralfkiaer E., Dallenbach F., Stein H. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood. 1995 Aug 15;86(4):1453–1459. [PubMed] [Google Scholar]
  13. Ngan B. Y., Picker L. J., Medeiros L. J., Warnke R. A. Immunophenotypic diagnosis of non-Hodgkin's lymphoma in paraffin sections. Co-expression of L60 (Leu-22) and L26 antigens correlates with malignant histologic findings. Am J Clin Pathol. 1989 May;91(5):579–583. doi: 10.1093/ajcp/91.5.579. [DOI] [PubMed] [Google Scholar]
  14. Orazi A., Cattoretti G., John K., Neiman R. S. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections. Mod Pathol. 1994 Jun;7(5):582–586. [PubMed] [Google Scholar]
  15. Perkins S. L., Kjeldsberg C. R. Immunophenotyping of lymphomas and leukemias in paraffin-embedded tissues. Am J Clin Pathol. 1993 Apr;99(4):362–373. doi: 10.1093/ajcp/99.4.362. [DOI] [PubMed] [Google Scholar]
  16. Picker L. J., Weiss L. M., Medeiros L. J., Wood G. S., Warnke R. A. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol. 1987 Jul;128(1):181–201. [PMC free article] [PubMed] [Google Scholar]
  17. Pinkus G. S., Pinkus J. L. Myeloperoxidase: a specific marker for myeloid cells in paraffin sections. Mod Pathol. 1991 Nov;4(6):733–741. [PubMed] [Google Scholar]
  18. Scheuermann R. H., Racila E. CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy. Leuk Lymphoma. 1995 Aug;18(5-6):385–397. doi: 10.3109/10428199509059636. [DOI] [PubMed] [Google Scholar]
  19. Silvestri F., Banavali S., Baccarani M., Preisler H. D. The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications. Haematologica. 1992 May-Jun;77(3):265–273. [PubMed] [Google Scholar]
  20. Soslow R. A., Bhargava V., Warnke R. A. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol. 1997 Oct;28(10):1158–1165. doi: 10.1016/s0046-8177(97)90254-9. [DOI] [PubMed] [Google Scholar]
  21. Verschuren M. C., Comans-Bitter W. M., Kapteijn C. A., Mason D. Y., Brouns G. S., Borst J., Drexler H. G., van Dongen J. J. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines. Leukemia. 1993 Dec;7(12):1939–1947. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES